Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The news is good for more than just an hour trade, people loading up @ $11-$12 here on huge record daily volume....there could be more updates coming IMO as the conference is still going on and they don't present until tomorrow I believe.
Wow my $12 opening target was way to low!
Do you really think it can run to $18??
$14 'S LOOK LIKE SOME RESIST IF BREAKS THRU NP, SHOULD BE NICE TO $16-18
NVCR
We may see $16.+ today. also still thinking we may run to $25. sometime this week. See how it plays out.
13.80'S SO FAR
NVCR
Might hit $14s before open strong recovery off the $12.35 dip.
PM Shares switching hands @ $12s and healthy pullback from $13.35 to $12.35.
Congrats they payed off looks like 13$s going p/m
We may have a runner! Watching at open for trend!
13.15x13.20 l;ol
NVCR GOOOOOO!
Wow amazing! This will at least double tomorrow!
CBS News Health Headline $NVCR
http://www.cbsnews.com/news/cancer-therapy-fights-brain-tumors-optune-novocure/
$NVCR look at recents like ESPR CBIO AKTX on the good news they had....NVCR has as much good news and more than those IMO with the 3 (yes 3!) positive phase PRs over the weekend including a critical phase 3 on brain cancer treatments. We will see tomorrow where it goes but it hit mid $10s on Friday in AH would have closed higher IMO if it wasn't so late Friday.....many traders closed shop by the time it was released.
Also add in the fact that they are releasing and presenting this information during the biggest cancer conference of the year.
Seriously??? You really think it can go that high?
A fastrack PR soon would be gravy on top of all this. No clue where it opens up but $11-$12 before opening bell isn't out of the question IMO.
Scottrade lets me trade @ 6:00AM EST. Massive gapper!
Phase 2 ovarian positive results; phase 2 pancreatic positive results and now critical 5yr phase 3 results on brain cancer treatment all released after market close and over the weekend. Are you kidding???? Some run nearly 100% on just one Positive results PR....NVCR has 3 in the last 48hrs!
Should run way past $25.+ this week. Upside gapper @ opening bell.
Increasing Brain Cancer Survival (Washington Post Today)
News article just released.
https://www.washingtonpost.com/news/to-your-health/wp/2017/04/02/brain-cancer-survival-improves-with-novel-electrical-device-data-show/?utm_term=.d317abdf797a
Boom
Hope about my 11's and 14's :( just looking for some GREEN
Was unlucky to get some $8s but hopefully those low $9s pay off big tomorrow. Huge phase 3 increased survival results + good after hours news last Friday could be a rocket ship tomorrow? We will see!
From your lips to Gods ears!!
Huge Phase 3 5yr trials completed news released this morning. Could pull a double tomorrow in this tiny float coupled with the late Friday after close news!
Late Friday news keep on radar next week could go bonkers more news to follow?
Pomona Capital VII, L.P. has filed a new 13G, reporting 11.3% ownership in $NVCR - https://fintel.io/so/us/nvcr
* * $NVCR Video Chart 11-02-16 * *
Link to Video - click here to watch the technical chart video
No news makes for a boring company
What happened?
Headed to $9 imo
Wow what's happening-GREEN?
Novocure Converts More Than 500 U.S. Patients to Second Generation Optune within Four Weeks of FDA Approval on July 13
They still showed good improvement on the prescription base though. This company is funding many different trials right now....and earnings releases will dog this company for a while because of that. Until I see indications that
this novel approach to cancer is shy on meeting its endpoints, I'm in.
Analyst's lofty expectations drove this stock price down...not the actual performance of the product. Novel approaches to curing cancer are always met with skepticism, which automatically dictates a slow and steady build.
Analysts never pay attention to this reality.
Having a commercial product that is viable is huge. This keeps this company alive and in play for the foreseeable future.
I agree but the disconnect during quarterly earnings- 50% drops!!!!! This company had $29 IPO intentions and we sit at $7.50
going to be a lot of cash burn that will out pace revenues for at least 3 more years. Still.....it's a prove commercial technology. These would be the best levels to buy it at and check back in 2 years from now.
It won't be earnings releases that will bolster the share price anytime soon, rather an announcement that Medicare is coming on board, which is going to happen, and will be the biggest catalyst for this company.
That could happen in the next 18 months.
Not anymore lol. Terrible company execs-bloated pig
This company sucks and Doyle is awful
Followers
|
28
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
553
|
Created
|
10/07/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |